National Health Investors (NHI) reported mixed Q2 results, with earnings per share of $0.79—exceeding analyst expectations by four cents—while revenue reached $70.27 million, surpassing estimates. Despite this, the stock remains volatile, declining 5.28% over three months. The healthcare REIT announced a strategic partnership to add six senior living facilities to its portfolio, marking its first multi-property RIDEA-structured deal, which promises deeper operational collaboration. Meanwhile, NHI raised its Q3 dividend to $0.92 per share, signaling confidence despite a year-over-year earnings dip attributed to $1.3 million in proxy fight costs. Adjusted Funds From Operations (FFO) rose to $1.22 per share, reflecting operational strength.
Strategic Shifts and Expansion
NHI completed the transition of six Discovery Senior Living facilities into its SHOP portfolio, sacrificing $8.8 million in near-term rental income but positioning for higher long-term yields. The SHOP segment already showed a 29.4% increase in net operating income. With $750 million available for acquisitions and a pipeline of $129.9 million under contract, NHI targets an 8% average initial yield. Analysts note its robust balance sheet (3.9x net debt-to-EBITDA) but remain divided on outlooks as the REIT pivots toward operational partnerships.
Ad
National Health Investors Stock: Buy or Sell?! New National Health Investors Analysis from September 22 delivers the answer:
The latest National Health Investors figures speak for themselves: Urgent action needed for National Health Investors investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 22.
National Health Investors: Buy or sell? Read more here...